Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022010328 - 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES

Publication Number WO/2022/010328
Publication Date 13.01.2022
International Application No. PCT/KR2021/008850
International Filing Date 09.07.2021
IPC
C07D 233/96 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
233Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
96having three double bonds between ring members or between ring members and non-ring members
C07D 401/06 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
C07D 403/06 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
C07D 401/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
C07D 403/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
14containing three or more hetero rings
A61K 31/4166 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41641,3-Diazoles
4166having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
Applicants
  • 덕성여자대학교 산학협력단 DUKSUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR]/[KR]
  • 강원대학교 산학협력단 KNU- INDUSTRY COOPERATION FOUNDATION [KR]/[KR]
  • 동아대학교 산학협력단 DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION [KR]/[KR]
  • 영남대학교 산학협력단 INDUSTRY ACADEMIC COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY [KR]/[KR]
  • 이화여자대학교 산학협력단 EWHA UNIVERSIRY - INDUSTRY COLLABORATION FOUNDATION [KR]/[KR]
Inventors
  • 이상협 LEE, Sang Hyup
  • 최동영 CHOI, Dong Young
  • 이정관 LEE, Jungkwan
  • 안성훈 AHN, Sung Hoon
  • 최선 CHOI, Sun
  • 조현성 CHO, Hyun Sung
  • 김초롱 KIM, Cho Rong
  • 임유진 LIM, Yoo Jin
  • 김예은 KIM, Ye Eun
  • 이윤지 LEE, Yoonji
Agents
  • 특허법인 한성 HANSUNG INTELLECTUAL PROPERTY
Priority Data
10-2020-008554910.07.2020KR
Publication Language Korean (ko)
Filing Language Korean (KO)
Designated States
Title
(EN) 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES
(FR) 1-ALKYL-5-ARYLIDÈNE-2-SÉLÉNOOXOIMIDAZOLIDINE-4-ONE ET SON DÉRIVÉ, SON PROCÉDÉ DE PRÉPARATION ET COMPOSITION LE COMPRENANT POUR PRÉVENIR, SOULAGER OU TRAITER DES MALADIES NEURODÉGÉNÉRATIVES
(KO) 1-알킬-5-아릴리덴-2-셀레녹소이미다졸리딘-4-온 및 그 유도체, 이의 제조방법 및 이를 포함하는 신경퇴행성 질환의 예방, 개선 또는 치료용 조성물
Abstract
(EN) The present invention relates to 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and a derivative thereof, a preparation method therefor, and a composition comprising same for preventing, alleviating or treating neurodegenerative diseases. Specifically, 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and a derivative thereof, of the present invention, can be used as an excellent composition for preventing, alleviating or treating neurodegenerative diseases.
(FR) La présente invention concerne du 1-alkyl-5-arylidène-2-sélénooxoimidazolidine-4-one et son dérivé, son procédé de préparation et une composition le comprenant pour prévenir, soulager ou traiter des maladies neurodégénératives. Plus particulièrement, le 1-alkyl-5-arylidène-2-sélénooxoimidazolidine-4-one et son dérivé, selon la présente invention, peuvent être utilisés comme une excellente composition pour prévenir, soulager ou traiter des maladies neurodégénératives.
(KO) 본 발명은 1-알킬-5-아릴리덴-2-셀레녹소이미다졸리딘-4-온 및 그 유도체, 이의 제조방법 및 이를 포함하는 신경퇴행성 질환의 예방, 개선 또는 치료용 조성물에 관한 것이다. 구체적으로, 본 발명의 신규한 화합물인 1-알킬-5-아릴리덴-2-셀레녹소이미다졸리딘-4-온 및 그 유도체는 우수한 신경퇴행성 질환의 예방, 개선 또는 치료용 조성물로 사용될 수 있다. [대표도] 도 1
Latest bibliographic data on file with the International Bureau